Hunter E S, Kotch L E, Cefalo R C, Sadler T W
Developmental and Reproductive Toxicology Group, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.
Fundam Appl Toxicol. 1995 Dec;28(2):177-86. doi: 10.1006/faat.1995.1158.
Cocaine use has been associated with adverse developmental effects in humans. However, clinical reports both confirm and deny an association between cocaine use and malformations. Similarly, differences in species and strain, as well as route and timing of cocaine administration, have added to the difficulties in determining the teratogenicity of cocaine in animal models. This study was undertaken to compare the effects of dose, route, and timing of cocaine administration in ICR mice during early organogenesis. A single intraperitoneal (ip) administration of cocaine ( > or = 60 mg/kg) on Day 9 of gestation (plug day = 1) produced maternal lethality. The predominant developmental effect of cocaine administration was an increase in the percentage of litters exhibiting an enlarged renal pelvis. Despite a high incidence of affected pups at these doses, the enlargement was not severe. These results, in agreement with previous reports, provide further evidence that the developing urogenital system is sensitive to cocaine administration. When cocaine was administered using a subcutaneous route, pup weights were greater and the incidence of enlarged renal pelvis was lower than when an ip route was used. To better mimic human binge cocaine abuse, the toxicity of a "split dose" was determined. A 60 mg/kg dose was administered using one administration of 60 mg/kg, two treatments of 30 mg/kg, or three administrations of 20 mg/kg with 1 hr separating the treatments. The incidence of enlarged renal pelvis was similar when cocaine was administered as one or two but was decreased when cocaine was administered as three treatments. Both the route and split-dose studies suggest that high-peak serum concentrations are required to perturb development. There were no differences in the incidence or severity of enlarged renal pelvis when cocaine was administered on Day 8, 9, or 10 or on all 3 days of gestation. This suggested that the increase in enlarged renal pelvis may not be a specific teratogenic effect of cocaine administration but may be a delay of normal development induced by cocaine exposure during this early period of organogenesis. To address this hypothesis, cocaine was administered on Day 9 using an ip route and the pups were allowed to be naturally born. In pups whose mothers received cocaine there was an increase in postnatal deaths and a trend toward a reduction in pup body weight/litter at Postnatal Day 21. However, when renal morphology was assessed on Postnatal Day 21 no abnormal kidneys were seen. This supports the hypothesis that enlarged renal pelvis produced by cocaine administration during early organogenesis represents a developmental delay and not a persistent teratogenic defect. These studies suggest that high peak cocaine concentrations are required to delay normal kidney morphogenesis in mice.
可卡因的使用已被证实与人类发育的不良影响有关。然而,临床报告对可卡因使用与畸形之间的关联既有肯定也有否定。同样,物种和品系的差异,以及可卡因给药的途径和时间,都增加了在动物模型中确定可卡因致畸性的难度。本研究旨在比较在ICR小鼠早期器官形成期间,可卡因给药的剂量、途径和时间的影响。在妊娠第9天(交配日=1)单次腹腔注射(ip)可卡因(≥60mg/kg)会导致母体死亡。可卡因给药的主要发育影响是出现肾盂扩大的窝数百分比增加。尽管在这些剂量下受影响幼崽的发生率很高,但扩大并不严重。这些结果与之前的报告一致,进一步证明发育中的泌尿生殖系统对可卡因给药敏感。当采用皮下途径给药时,幼崽体重更大,肾盂扩大的发生率低于腹腔注射途径。为了更好地模拟人类滥用可卡因的暴饮暴食情况,测定了“分剂量”的毒性。采用一次60mg/kg、两次30mg/kg或三次20mg/kg的给药方式,每次给药间隔1小时,给予60mg/kg剂量。当可卡因以一次或两次给药时,肾盂扩大的发生率相似,但当以三次给药时则降低。途径和分剂量研究均表明,需要高血清峰值浓度才能干扰发育。在妊娠第8天、第9天或第10天或整个妊娠3天给予可卡因时,肾盂扩大的发生率和严重程度没有差异。这表明肾盂扩大的增加可能不是可卡因给药的特定致畸作用,而是在器官形成早期接触可卡因所导致的正常发育延迟。为了验证这一假设,在第9天采用腹腔注射途径给予可卡因,并让幼崽自然出生。在其母亲接受可卡因的幼崽中,出生后死亡增加,并且在出生后第21天有幼崽体重/窝重降低的趋势。然而,在出生后第21天评估肾脏形态时,未发现异常肾脏。这支持了这样的假设,即在早期器官形成期间可卡因给药导致的肾盂扩大代表发育延迟而非持续性致畸缺陷。这些研究表明,需要高可卡因峰值浓度才能延迟小鼠正常肾脏形态发生。